CENTENE CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.1 USD | +1.64% |
|
+3.65% | +3.81% |
| May. 02 | Barclays Adjusts Price Target on Centene to $104 From $101 | MT |
| Apr. 30 | Bernstein Adjusts Centene's Price Target to $94 From $100 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 149B | Sales 2025 * | 155B | Capitalization | 40.48B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.1B | Net income 2025 * | 3.25B | EV / Sales 2024 * | 0.29 x |
| Net Debt 2024 * | 2.41B | Net cash position 2025 * | 1.83B | EV / Sales 2025 * | 0.25 x |
| P/E ratio 2024 * |
12.8
x | P/E ratio 2025 * |
11.6
x | Employees | 67,700 |
| Yield 2024 * |
-
| Yield 2025 * |
2.2% | Free-Float | 86.31% |
More Fundamentals
* Assessed data
More news
Latest transcript on Centene Corporation
More recommendations
More press releases
More news
| 1 day | -0.07% | ||
| 1 week | +4.98% | ||
| Current month | +3.82% | ||
| 1 month | +3.93% | ||
| 3 months | -0.85% | ||
| 6 months | +7.88% | ||
| Current year | +2.21% |
1 week
73.78
76.43
1 month
70.0676.44
Current year
70.0681.42
1 year
60.8381.42
3 years
59.6798.53
5 years
41.6298.53
10 years
17.0498.53
| Managers | Title | Age | Since |
|---|---|---|---|
Sarah London
CEO | Chief Executive Officer | 43 | 20-08-31 |
Drew Asher
DFI | Director of Finance/CFO | 55 | 19-12-31 |
Kenneth Fasola
PSD | President | 64 | 22-07-05 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Monte Ford
BRD | Director/Board Member | 64 | 22-11-11 |
| Director/Board Member | 71 | 21-12-31 | |
| Chairman | 65 | 06-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.63% | 0 M€ | +7.73% | - | |
| 1.41% | 0 M€ | +5.74% | - | |
| 1.31% | 0 M€ | +8.89% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 77.08 | +1.62% | 943 369 |
| 24-05-08 | 75.85 | -0.07% | 2,707,463 |
| 24-05-07 | 75.9 | +1.01% | 2,534,532 |
| 24-05-06 | 75.14 | +0.44% | 2,780,170 |
| 24-05-03 | 74.81 | +0.65% | 4,706,732 |
Delayed Quote Nyse, May 08, 2024 at 04:00 pm EDT
More quotes
Centene Corporation specializes in health services. Revenues break down by activity as follows:
- development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons;
- specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
Managed Healthcare
Calendar
2024-05-13
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
75.85
USD
Average target price
89.12
USD
Spread / Average Target
+17.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.21% | 40.48B | |
| -4.42% | 463B | |
| +13.10% | 124B | |
| +16.00% | 98.67B | |
| -29.20% | 39.06B | |
| -4.68% | 20.18B | |
| -13.50% | 3.09B | |
| -21.25% | 1.3B | |
| -8.56% | 432M |
- Stock Market
- Equities
- CNC Stock